Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 7.69 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $39.007 million which missed the analyst consensus estimate of $40.067 million by 2.65 percent. This is a 1.91 percent decrease over sales of $39.766 million the same period last year.